34 results
Page 2 of 2
8-K
EX-99.1
75rj q6rbz72ny
24 Feb 22
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results
4:27pm
8-K
EX-99.2
9o2su5mmcigbcf87x
27 May 21
GSK and Vir Biotechnology Announce Sotrovimab (VIR-7831) Receives
4:55pm
8-K
EX-99.1
mjox8h vbs
27 May 21
GSK and Vir Biotechnology Announce Sotrovimab (VIR-7831) Receives
4:55pm
8-K
EX-99.1
gcrfl963t38ndw1w2g
13 Apr 21
Other Events
4:06pm
8-K
EX-99.1
dq78obanzlis
19 Feb 21
GSK and Vir Biotechnology Expand Coronavirus Collaboration to Advance New Therapeutics for Influenza and Other Respiratory Viruses
5:03pm
8-K
EX-99.2
rqag8n wxik
28 Jan 21
Other Events
4:05pm
8-K
EX-99.1
xpk kscy3
11 Aug 20
Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2020 Financial Results
4:05pm
8-K
yalf8m 0ds49
6 Jul 20
Our mission is to create a world without infectious disease
6:32am
8-K
EX-99.1
srrpa52n29bgnm302crx
6 Apr 20
Entry into a Material Definitive Agreement
8:02am
S-1
EX-10.35
5mvm7e5jb ypyhi
3 Sep 19
IPO registration
4:40pm
S-1
EX-10.16
c3mcu wtuj
3 Sep 19
IPO registration
4:40pm
DRS/A
EX-10.16
qdnlv5iuge9hi
7 Aug 19
Draft registration statement (amended)
12:00am
DRS/A
EX-10.35
r9s0dgvb rld50oh3jj
7 Aug 19
Draft registration statement (amended)
12:00am